-
-
-
-
-
-
-
Yunqi Capital opposes STAAR merger with Alcon despite revised offer
-
-
-
-
-
-
-
Alcon raises STAAR acquisition price to $30.75 per share
-
-
-
-
-
-
-
STAAR Surgical Announces Amendments to Alcon Merger Agreement
-
-
-
-
-
-
-
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
-
-
-
-
-
-
-
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
-
-
-
-
-
-
-
Broadwood opposes STAAR Surgical acquisition by Alcon
-
-
-
-
-
-
-
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

